These results suggest that the efficacy of grass pollen sublingual immunotherapy can be assessed by EBT , a putative quantitative measurement of airway inflammation , which is superior in its power to discriminate between active and placebo treatment than a subjective assessment of symptoms assessed on a visual analog scale .